BioSpace News Archive

ADx Healthcare, a physician-owned provider of Alzheimer’s disease-related testing, today announced the launch of its Alzheimer’s Disease APOE genetic test in partnership with Helix, a personal genomics company.

Millions of Americans take medication daily to control their blood pressure. We recently found that some generic versions of one medication, valsartan, contain an impurity that doesn’t meet FDA’s safety standards.

Competitors Lining Up For Chance to Win Investment and Pilot Prizes at Second-Ever Pitch Event at the Healthcare Revolution Conference. Applications Now Being Accepted.

There is a dire diabetes epidemic on the island of Guam, a United States territory, and to add to the devastation, there are minimal data to inform solutions.

A farm in Lower Saxony with sow breeding, floor-feeding laying hens and biogas plant is installing a BlueBox Ultra for the treatment of manure from the Swiss agri-tech company Bluetector. The Bluetector plant that turns manure into water will treat up to 26.000 gallons of manure per day.

HEMLIBRA prophylaxis significantly reduced bleeds compared to no prophylaxis

BerGenBio ASA announces that Richard Godfrey, CEO of BerGenBio, is scheduled to present an overview of the Company’s business and ongoing phase II clinical development programme with its first-in-class selective AXL inhibitor bemcentinib at the 20th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC, on September 5th 2018 at 9:35 AM (Eastern Time).

Schrödinger, Inc. announced today that the Company will participate in a panel discussion entitled “Emerging Innovators - An Introduction to Biotech Privates” at the Citi 13th Annual Biotech Conference

Celling Bioscience has signed an exclusive Agreement with RxBIO to launch its brand of products in Canada.

RootPath today announced a $7 million seed funding round led by Sequoia China with participation from Volcanics Venture, BV (Baidu Ventures) and Nest.Bio Ventures.